Pakistan Journal of Pharmaceutical Sciences
Overview
The Pakistan Journal of Pharmaceutical Sciences is a peer-reviewed academic journal that publishes original research articles, reviews, and case studies in the field of pharmaceutical sciences. It aims to promote the advancement of pharmaceutical knowledge and contribute to the development of the pharmaceutical industry in Pakistan and beyond. The journal covers various aspects of pharmaceutical sciences, including drug discovery, formulation, pharmacology, pharmacokinetics, and pharmaceutical technology.
Details
Details
Abbr.
Pak J Pharm Sci
Start
1988
End
Continuing
Frequency
Bimonthly, Jan. 2013-
p-ISSN
1011-601X
Country
Pakistan
Language
English
Specialties
Pharmacology
Chemistry
Chemistry
Metrics
Metrics
h-index / Ranks: 7562
48
SJR / Ranks: 13403
209
CiteScore / Ranks: 11545
1.60
JIF / Ranks: 7093
0.8
Recent Articles
1.
Qin D, Ren Y, Zhang N, Yang X, Chen Z, Zhao C
Pak J Pharm Sci
. 2025 Mar;
38(1):77-82.
PMID: 40089933
To evaluate the comparative efficacy of Ticagrelor and Clopidogrel in treating patients with coronary heart disease and unstable angina, as well as their effects on serum inflammatory factors, thereby providing...
2.
Zhao Z, Liu J, Huang J
Pak J Pharm Sci
. 2025 Mar;
38(1):71-75.
PMID: 40089932
To compare the drug effects and adverse reactions of doxycycline and isotretinoin in patients with moderate to severe acne. A retrospective analysis was conducted on 98 patients with moderate to...
3.
Liu J, Liu D, Wang L
Pak J Pharm Sci
. 2025 Mar;
38(1):61-70.
PMID: 40089931
Myeloma nephropathy is a rare but challenging disease. This study aimed to evaluate the efficacy and renal functional outcomes of the VAD chemotherapy regimen and thalidomide treatment for myeloma nephropathy....
4.
Patel B, Ishaq H, Patel M, Iqbal A, Alam S, Orayj K, et al.
Pak J Pharm Sci
. 2025 Mar;
38(1):55-60.
PMID: 40089930
Hyperkalemia poses significant risks to patients due to its potential to cause life-threatening cardiac and neuromuscular complications. This study aimed to evaluate the effectiveness of different treatment protocols for hyperkalemia...
5.
Zhang M, Liu Y, Sun X, Zhang X, Hua L
Pak J Pharm Sci
. 2025 Mar;
38(1):45-53.
PMID: 40089929
Myocardial infarction (MI), a leading cause of global mortality, often leads to heart failure and impaired quality of life. This randomized controlled trial evaluated Salvia miltiorrhiza (SM), a traditional Chinese...
6.
Wang J, Wang J, Zhu Y, Ma S, Hu J
Pak J Pharm Sci
. 2025 Mar;
38(1):37-44.
PMID: 40089928
Upper limb spasticity is a common and serious sequelae in patients with hemiplegia after stroke. Radial extracorporeal shock wave therapy (rESWT) can improve upper limb dysfunction and relieve pain in...
7.
Feng B, Zhang S, Sun D
Pak J Pharm Sci
. 2025 Mar;
38(1):25-35.
PMID: 40089927
This study explores the effect of aspirin on preeclampsia (PE) and analyzes the influencing factors of PE in high-risk pregnant women. We encompassed 110 high-risk pregnant women receiving prenatal examination...
8.
Akhtar M, Shaik Alavudeen S, Orayj K, Tabassum F, Salman Almujri S, Alshaiban A, et al.
Pak J Pharm Sci
. 2025 Mar;
38(1):15-24.
PMID: 40089926
Risk assessment for cardiovascular diseases (CVD) is fundamental to prevention, enabling early intervention when risks are recognized. This cross-sectional study focuses on evaluating the knowledge, attitude, practices and perceived barriers...
9.
Zahid H, Hina B, Abbas K
Pak J Pharm Sci
. 2025 Mar;
38(1):7-14.
PMID: 40089925
Prevalence of gastric diseases caused by Helicobacter Pylori bacteria is very common especially in developing countries. H. pylori is not only responsible for initiating gastric complaints like gastritis and peptic...
10.
Lan X, Sun H, Shi K, Sun X, Wang T, Wang H
Pak J Pharm Sci
. 2025 Mar;
38(1):1-6.
PMID: 40089924
Caltrate D is a commonly used drug in the treatment of postmenopausal osteoporosis (PMOP), but the effect of single application is not ideal. Therefore, to investigate the eight section brocade...